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Abstract
Background Patient-reported outcome measures such as
the Patient-Reported Outcomes Measurement Information
System (PROMIS) allow surgeons to evaluate the most
important outcomes to patients, including function, pain,
and mental well-being. However, PROMIS does not provide surgeons with insight into whether patients are able to

successfully cope with their level of physical and/or mental
health limitations in day-to-day life; such understanding
can be garnered using the Patient-acceptable Symptom
State (PASS). It remains unclear whether or not the PASS
status for a given patient and his or her health, as evaluated
by PROMIS scores, differs based on sociodemographic
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factors; if it does, that could have important implications
regarding interpretation of outcomes and fair delivery of
care.
Questions/purposes In a tertiary-care foot and ankle
practice, (1) Is the PASS associated with sociodemographic factors (age, gender, race, ethnicity, and income)?
(2) Do PROMIS Physical Function (PF), Pain Interference
(PI), and Depression scores differ based on income level?
(3) Do PROMIS PF, PI, and Depression thresholds for the
PASS differ based on income level?
Methods In this retrospective analysis of longitudinally
obtained data, all patients with foot and ankle conditions
who had new-patient visits (n = 2860) between February
2015 and December 2017 at a single tertiary academic
medical center were asked to complete the PROMIS PF,
PI, and Depression survey and answer the following single, validated, yes/no PASS question: “Taking into account all the activity you have during your daily life, your
level of pain, and also your functional impairment, do you
consider that the current state of your foot and ankle is
satisfactory?” Of the 2860 new foot and ankle patient
visits, 21 patient visits (0.4%) were removed initially because all four outcome measures were not completed. An
additional 225 patient visits (8%) were removed because
the patient chart did not contain enough information to
accurately geocode them; 15 patients visits (0.5%) were
removed because the census block group median income
data were not available. Lastly, two patient visits (0.1%)
were removed because they were duplicates. This left a
total of 2597 of 2860 possible patients (91%) in our study
sample who had completed all three PROMIS domains
and answered the PASS question. Patient sociodemographic factors such as age, gender, race, and ethnicity
were recorded. Using census block groups as part of a
geocoding method, the income bracket for each patient
was recorded. A chi-square analysis was used to determine
whether sociodemographic factors were associated with
different PASS rates, two-way ANOVA analyses with
pairwise comparisons were used to determine if PROMIS
scores differed by income bracket, and a receiver operating
characteristic (ROC) curve analysis was performed to
determine PASS thresholds for the PROMIS score by income bracket. The minimum clinically important difference (MCID) for PROMIS PF in the literature in foot and
ankle patients ranges from about 7.9 to 13.2 using anchorbased approaches and 4.5 to 4.7 using the ½ SD,
distribution-based method. The MCID for PROMIS PI in
the literature in foot and ankle patients ranges from about
5.5 to 12.4 using anchor-based approaches and about 4.1 to
4.3 using the ½ SD, distribution-based method. Both were
considered when evaluating our ﬁndings. Such MCID
cutoffs for PROMIS Depression are not as well established
in the foot and ankle literature. Signiﬁcance was set a priori
at p < 0.05.

Results The only sociodemographic factor associated with
differences in the proportion of patients achieving PASS
was age (15% [312 of 2036] of patients aged 18-64 years
versus 11% [60 of 561] of patients aged $ 65 years; p =
0.006). PROMIS PF (45 6 10 for the $ USD 100,000
bracket versus 40 6 10 for the # USD 24,999 bracket,
mean difference 5 [95% CI 3 to 7]; p < 0.001), PI (57 6 8
for $ USD 100,000 versus 63 6 7 for # USD 24,999,
mean difference -6 [95% CI -7 to -4]; p < 0.001), and
Depression (46 6 8 for the $ USD 100,000 bracket versus
51 6 11 for # USD 24,999, mean difference -5 [95% CI -7
to -3]; p < 0.001) scores were better for patients in the
highest income bracket compared with those in the lowest
income bracket. For PROMIS PF, the difference falls
within the score change range deemed clinically important
when using a ½ SD, distribution-based approach but not
when using an anchor-based approach; however, the score
difference for PROMIS PI falls within the score change
range deemed clinically important for both approaches.
The PASS threshold of the PROMIS PF for the highest
income bracket was near the mean for the US population
(49), while the PASS threshold of the PROMIS PF for the
lowest income bracket was more than one SD below the US
population mean (39). Similarly, the PASS threshold of the
PROMIS PI differed by 6 points when the lowest and
highest income brackets were compared. PROMIS Depression was unable to discriminate the PASS.
Conclusions Discussions about functional and pain goals
may need to be a greater focus of clinic encounters in
the elderly population to ensure that patients understand
the risks and beneﬁts of given treatment options at their
advanced age. Further, when using PASS in clinical
encounters to evaluate patient satisfaction and the ability to
cope at different symptom and functionality levels, surgeons should consider income status and its relationship to
PASS. This knowledge may help surgeons approach
patients with a better idea of patient expectations and which
level of symptoms and functionality is satisfactory; this
information can assist in ensuring that each patient’s health
goal is included in shared decision-making discussions. A
better understanding of why patients with different income
levels are satisﬁed and able to cope at different symptom
and functionality levels is warranted and may best be accomplished using an epidemiologic survey approach.
Level of Evidence Level III, diagnostic study.

Introduction
Use of patient-reported outcome measures (PROMs) allow
surgeons to evaluate clinical outcomes that matter most to
patients, and there is a growing call to expand their use in
routine clinical care [3]. Several validated PROMs have
been used in research and in clinical settings, including the

Patient-Reported Outcomes Measurement Information
System (PROMIS) [11]. PROMIS is a universal PROM
developed with the support of the National Institutes of
Health that provides an innovative way to measure outcomes
normed to the US population [5]. PROMIS domains
provide a measure of general health and can complement
disease-speciﬁc PROMs such as the Foot and Ankle Ability
Measure, Hip Disability and Osteoarthritis Outcome Score,
and Knee Disability and Osteoarthritis Outcome Score.
However, while PROMIS has been validated for several
patient factors across the population [5], there is a paucity of
studies evaluating whether PROMIS scores differ based on
sociodemographic factors. Examples of sociodemographic
factors include age, gender, race, ethnicity, and income [21].
We are only aware of two sociodemographic factor-focused
studies using the PROMIS, in patients with hand conditions,
which are both limited in scope [16, 23]. Therefore, how
surgeons best tailor care using PROMIS based on sociodemographic factors is unclear. While PROMIS provides
insight into a patient’s symptom and functional level compared with the US population, it does not provide insight
into a patient’s ability to cope with their current health status.
Such understanding can be discerned using the Patientacceptable Symptom State (PASS), a single question that
determines a patient’s ability to adapt to his or her current
health status by evaluating whether the patient’s current
symptom and activity levels are satisfactory [1, 13, 15].
Thus, it may provide a convenient way for patients to express their feelings associated with their level of symptoms
and overall health. However, the relationship between
sociodemographic factors, PROMIS, and PASS scores in
foot and ankle patients has not been clearly deﬁned.
Therefore, in a tertiary-care foot and ankle practice, we
asked: (1) Is the PASS associated with sociodemographic
factors (age, gender, race, ethnicity, and income)? (2) Do
PROMIS Physical Function (PF), Pain Interference (PI),
and Depression scores differ based on income level? (3) Do
PROMIS PF, PI, and Depression thresholds for the PASS
differ based on income level?

Patients and Methods
Patient Sample
The appropriate institutional review board approved this
study, which is a retrospective analysis of longitudinally
obtained data. Between February 2015 and December
2017, all new patients (n = 2860) presenting to the orthopaedic foot and ankle clinic at an urban, tertiary care, academic medical center were asked to complete the
PROMIS PF, PI, and Depression computer adaptive tests
on Apple iPads (Apple, Cupertino, CA, USA) as part of
routine clinical care [17]. In addition to PROMIS domains,

patients were also asked a single, validated, yes/no question known as the PASS. To be included in our study,
patients were required to have answered all PROMs. Of the
2860 new foot and ankle patient visits, 21 patient visits
(0.4%) were removed initially because all four outcome
measures were not completed. An additional 225 patient
visits (8%) were removed because the patient chart did not
contain enough information to accurately geocode them;
15 patient visits (0.5%) were removed because the census
block group median income data were not available.
Lastly, two patient visits (0.1%) were removed because
they were duplicates. This led to our ﬁnal sample of 2597
patients (91%) (Fig. 1).
Patient characteristics including age (18-65 years or older
than 65 years), gender (man or woman), self-reported race
(white, black, other, or missing data), and ethnicity (Hispanic, non-Hispanic, or missing data) were determined from
patient medical records. Census block groups were identiﬁed
for each patient based on their address on the date of their
new-patient visit. Patient median income was determined
using block-level data from the 2017 American Community
Survey 5-year Estimates (https://factﬁnder.census.gov).
We converted income to six brackets based on the median income, as follows: # USD 24,999, USD 25,000-USD
34,999, USD 35,000-USD 49,999, USD 50,000-USD
74,999, USD 75,000-USD 99,000, and $ USD 100,000.
Although individualized measures are preferred, a great deal
of research involving income now uses validated area-based
status measures because of the lack of individual data in
clinical settings [12, 16, 23].
Although our sample was generally similar to the population of the surrounding county, it included slightly more
women and fewer black and Hispanic patients (Table 1)
[20]. The median income (USD) of our patients was higher
than that of people in our county (Table 1) [20].

PROMs Used
The PROMIS is a reliable, general PROM normed to the
population with a mean t-score of 50 and an SD of 10 [5, 8,
14]. Higher PROMIS PF scores indicate better physical
function compared with lower PROMIS PF scores. Lower
PROMIS PI and Depression scores indicate decreased pain
interference and lower depression, respectively, compared
with higher scores. The minimum clinically important
difference (MCID) for PROMIS PF in the literature in foot
and ankle patients ranges from about 7.9 to 13.2 using
anchor-based approaches and about 4.5 to 4.7 using the ½
SD, distribution-based method; the MCID for PROMIS PI
in the literature in foot and ankle patients ranges from about
5.5 to 12.4 using anchor-based approaches and about 4.1 to
4.3 using the ½ SD, distribution-based method [10]. Such
MCID cutoffs for PROMIS Depression are not as well

Fig. 1 This STROBE diagram illustrates the pathway from the total possible patient sample
to the ﬁnal sample used for all analyses.

established in the foot and ankle literature. Both the distribution- and anchor-based approaches were considered
when evaluating our ﬁndings. The computer-adaptive
testing approach commonly employed when administering PROMIS allows for greater precision in measuring
outcomes with fewer questions asked [6]. Further, collecting PROMs using Apple iPads has been shown to be
more efﬁcient than and preferable to traditional pen-andpaper collection methods [24].
In addition to PROMIS domains, patients were also
asked a single, validated, yes/no question known as the
PASS; as previously noted, this question determines a
patient’s ability to adapt to his or her current health status
by evaluating whether the patient’s current symptom and
activity levels are satisfactory [1, 13, 15]. The PASS
question is: “Taking into account all the activity you have
during your daily life, your level of pain, and also your
functional impairment, do you consider that the current
state of your foot and ankle is satisfactory?”

Statistical Analysis
To answer our ﬁrst question, we conducted a chi-square
analysis of each dichotomous variable and the PASS. In
addition, for the race and ethnicity variables, white was
compared with black race and Hispanic was compared with
non-Hispanic ethnicity. Further, for income, a chi-square
analysis was used across income brackets to determine
whether the PASS was associated with the median
income level.

Our second question was answered using a two-way
ANOVA with pairwise comparisons. In the two-way
ANOVA, income level was the ﬁrst factor and a PROMIS
domain was the second; this allowed us to assess differences between income levels for each PROMIS scale.
Gender and age were included as covariates in this analysis.
Lastly, the third question was answered using a receiver
operating characteristic (ROC) curve analysis. The receiver
operating characteristic curve analysis allowed us to determine the threshold of the PASS for each PROMIS domain
in the entire sample and for each income bracket. The PASS
threshold is the PROMIS score cutoff that differentiates those
who reach PASS compared with those who do not. The area
under the curve and its respective 95% CI was reported to
understand the overall accuracy of each PROMIS domain in
determining the PASS. The shortest distance to “no errors” of
the ROC curve was used to objectively determine thresholds.
The shortest distance to “no errors” on the ROC curve was
also visually assessed to assure that the identiﬁed threshold
was consistent with the overall minimum. The sensitivity and
speciﬁcity were reported for each threshold to assess the
ability of the selected threshold to discriminate patients in
each income bracket. For all analyses, SPSS Statistics V25
(IBM Corp, Armonk, NY, USA ) was used. Signiﬁcance was
set a priori at p < 0.05.

Results
The only sociodemographic factor associated with the
proportion of patients achieving PASS was age (15% [312

Table 1. Patient characteristics
Sociodemographic factor
Age (years)
18-64
$ 65
Gender
Women
Race
White
Black
Other
Missing data
Ethnicity
Hispanic
Non-Hispanic
Missing/unreported
Median income, mean (range)
PASS
No
PROMIS score (SD)
PF
PI
Depression

Study sample, mean (%) (n = 2597)

Monroe County, NY, USA (%)
(population ‡ 18 years old = 590,637)*

2036 (78)
561 (22)

463,538 (78)
127,099 (22)

1598 (62)

307,131 (52)

2358 (91)
144 (6)
85 (3)
10 (0.4)

454,790 (77)
94,501 (16)
41,344 (7)

51 (2)
2541 (98)
5 (0.2)
USD 68,857 (USD 9724-USD 182,813)

51,976 (9)
413,445 (70)
124,033 (21)
USD 55,272 (N/A)

2225 (86)

N/A

43 (10)
59 (8)
48 (9)

N/A
N/A
N/A

*Estimate; PASS = Patient-acceptable Symptom State; PROMIS = Patient-reported Outcomes Measurement Information System;
PF = Physical Function; PI = Pain Interference.

of 2036] of patients aged 18 to 64 years versus $ 11% [60
of 561] of patients aged 65 years; p = 0.006) (Table 2).
However, the proportion of patients achieving PASS did
not differ by gender (15% [245 of 1598] of women versus
13% [127 of 999] of men; p = 0.064), race (14% [324 of
2358] of patients who were white versus 19% [28 of 144]
of patients who were black; p = 0.056), ethnicity (16% [8 of
51] of patients who were Hispanic versus 14% [371 of
2592] of patients who were non-Hispanic; p = 0.780), or
income (15% [13 of 89] of patients earning # USD 24,999
versus 14% [16 of 118] of patients earning USD 25,000 to
USD 34,999 versus 14% [60 of 429] earning USD 35,000
to USD 49,999 versus 15% [157 of 1083] earning USD
50,000 to USD 74,999 versus 15% [75 of 505] USD 75,000
to USD 99,999 versus $ 14% [51 of 373] earning USD
100,000; p = 0.900).
Mean PROMIS PF was 45 6 10 for patients in the $
USD 100,000 income bracket versus 40 6 10 for patients
in the # USD 24,999 bracket (mean difference 5 [95% CI 3
to 7]; p < 0.001) (Table 3). Mean PROMIS PI was 57 6 8
for the $ USD 100,000 bracket versus 63 6 7 for the #
USD 24,999 bracket (mean difference -6 [95% CI to 7 to
-4]; p < 0.001) (Table 4). The mean PROMIS-Depression
scores were better for patients in the highest income bracket

compared with those in the lowest income bracket (46 6 8
for the $ USD 100,000 income bracket versus 51 6 11 for
the # USD 24,999 bracket, mean difference -5 [95% CI -7
to -3]; p < 0.001) (Table 5). For PROMIS PF, the difference
falls within the score change range deemed clinically important when using a ½ SD, distribution-based approach
but not when using an anchor-based approach; however,
the score difference for PROMIS PI falls within the score
change range deemed clinically important for both
approaches. Patients in the highest income bracket demonstrated better mean PROMIS PF scores than did those in
any of the other income bracket (45 6 10 for $ USD
100,000 versus 40 6 10 for # USD 24,999, mean difference 5 [95% CI 3 to 7]; p < 0.001; 45 6 10 for $ USD
100,000 versus 41 6 10 for USD 25,000 to USD 34,999,
mean difference 4 [95% CI 2 to 6]; p < 0.001; 45 6 10
for $ USD 100,000 versus 41 6 9 for USD 35,000 to USD
49,999, mean difference 3 [95% CI 2 to 5]; p < 0.001; 45 6
10 $ USD 100,000 versus 43 6 10 for USD 50,000 to
USD 74,999, mean difference 2 [95% CI 1 to 3]; p = 0.001;
45 6 10 for $ USD 100,000 versus 43 6 10 for USD
75,000 to USD 99,999, mean difference 1 [95% CI 0 to 3];
p = 0.029) (Table 3). Only the mean difference between the
lowest income bracket and the highest income bracket was

Table 2. Comparison of PASS based on sociodemographic
status factors
Sociodemographic
factor
Age (years)
18-64
$ 65
Gender
Women
Men
Race
White
Black
Ethnicity
Hispanic
Non-Hispanic
Income
# USD 24,999
USD 25,000-USD 34,999
USD 35,000 USD 49,999
USD 50,000-USD 74,999
USD 75,000-USD 99,999
$ USD 100,000

PASS,
n (%)

No PASS,
n (%)

312 (15)
60 (11)

1724 (85)
501 (89)

245 (15)
127 (13)

1353 (85)
872 (87)

324 (14)
28 (19)

2034 (86)
116 (81)

p value
0.006

0.064

0.056

0.780
8 (16)
363 (14)

43 (84)
2178 (86)

13 (15)
16 (14)
60 (14)
157 (15)
75 (15)
51 (14)

76 (85)
102 (86)
369 (86)
926 (86)
430 (85)
322 (86)

0.900

PASS = Patient-acceptable Symptom State.

clinically important when using the ½ SD, distributionbased approach for determining MCID; no PROMIS PF
mean differences were clinically important when using
the anchor-based approach for determining the MCID.
PROMIS PI patients in the highest income bracket demonstrated better mean PROMIS PI scores than did those in
any of the other income bracket (57 6 8 for $ USD
100,000 versus 63 6 7 # USD 24,999, mean difference -6
[95% CI -4 to -7]; p < 0.001; 57 6 8 for $ USD 100,000
versus 61 6 8 for USD 25,000 to USD 34,999, mean difference -4 [95% CI-2 to -5]; p < 0.001; 57 6 8 for $ USD
100,000 versus 60 6 8 for USD 35,000 to USD 49,999,
mean difference -3 [95% CI -2 to -4]; p < 0.001; 57 6 8
for $ USD 100,000 versus 59 6 8 for USD 50,000 to USD
74,999, mean difference -2 [95% CI -3 to -1]; p < 0.001; 57
6 8 for $ USD 100,000 versus 59 6 8 for USD 75,000 to
USD 99,999, mean difference -2 [95% C, -1 to -3]; p <
0.001) (Table 4). Only the mean difference between the
lowest income bracket and the highest income bracket was
clinically important when using the ½ SD, distributionbased approach or anchor-based approach for determining
MCID. For PROMIS Depression, the highest income
bracket’s mean PROMIS scores were only lower than those
in the three lowest income brackets ($ 46 6 8 for USD
100,000 versus 51 6 11 for # USD 24,999, mean difference
-5 [95% CI -7 to -3]; p < 0.001; 46 6 8 for $ USD 100,000

versus 50 6 10 for USD 25,000 to USD 34,999, mean
difference -4 [95% CI -6 to -2]; p < 0.001; 46 6 8 for $ USD
100,000 versus 49 6 9 for USD 35,000 to USD 49,999,
mean difference -2 [95% CI -1 to -4]; p < 0.001) (Table 5).
Threshold PROMIS scores for all three domains differed based on income levels, especially from the highest
income bracket to the lowest income bracket. In addition,
the ability of PROMIS scales to discriminate the PASS
showed that the PROMIS PF and PI had higher area under
the curve (AUC) values than did the PROMIS Depression.
Overall, the PROMIS scores to achieve the PASS (“PASS
threshold”) were worse for lower-income patients than for
higher-income patients (Table 6). For the PROMIS PF and
PI, the AUC values across income brackets ranged from
0.59 to 0.79 (Table 6). An AUC value of 0.5 mean the
PROMIS score threshold is no better than chance at determining PASS, while an AUC value of 1 means the
threshold perfectly discriminates who will or will not
achieve PASS. The difference between thresholds for the
PROMIS was 10 points when we compared the lowest and
highest income brackets (Table 6). The PASS threshold of
the PROMIS PF for the highest income bracket was near
the mean of the US population (49), while the PASS
threshold of the PROMIS PF for the lowest income bracket
was more than one SD worse than the US population mean
(39) (Table 6). Similarly, the PASS threshold of the
PROMIS PI differed by 6 points when we compared
the lowest and highest income brackets (Table 6). The
PROMIS PI threshold for the highest income bracket was
near normal for the US population (53), while that for the
lowest income bracket was nearly one SD worse than
normal (59) (Table 6). The PROMIS Depression showed
poor ability to determine the PASS (Table 6).

Discussion
PROMs, such as PROMIS, provide surgeons a validated
way to evaluate clinical outcomes that matter most to
patients; however, such tools do not provide insight into the
ability of patients to cope successfully with their current
symptom and functional status. In contrast, PASS, a single,
validated, yes/no question determines a patient’s ability to
adapt to his or her current health status. While both PROMIS
and PASS may add value to patient care, there is limited
work evaluating the relationship between the two instruments, including when considering patient sociodemographic factors such as income. We found that only age was
associated with a difference in the PASS rate, while gender,
race, ethnicity, and income bracket were not. Second,
patients in lower income brackets reported worse symptoms
(PROMIS domain scores) than did those in higher income
brackets with the difference between the highest and lowest
income bracket for PROMIS PF being clinically important

Table 3. Two-way ANOVA with pairwise comparison to evaluate diﬀerences in mean PROMIS PF scores by income bracket*
Income bracket: mean PROMIS PF score (SD) (horizontal column) versus mean PROMIS PF score (SD) (vertical column)
Income bracket
# USD 24,999 (n = 89)
p value
USD 25,000-USD
34,999 (n = 118)
p value
USD 35,000-USD
49,999 (n = 429)
p value
USD 50,000-USD
74,999 (n = 1083)
p value
USD 75,000-USD
99,999 (n = 505)
p value
$ USD 100,000
(n = 373)
p value

£ USD 24,999
(n = 89)

USD 25,000 to USD
34,999 (n = 118)

USD 35,000 to USD
49,999 (n = 429)

USD 50,000 to USD
74,999 (n = 1083)

USD 75,000 to USD
99,999 (n = 505)

40 (10) vs. 41 (10)
p = 0.365
40 (10) vs. 41 (9)

41 (10) vs. 41 (9)

p = 0.203
40 (10) vs. 43 (10)

p = 0.838
41 (10) vs. 43 (10)

41 (9) vs. 43 (10)

p = 0.005
40 (10) vs. 43 (10)

p = 0.057
41 (10) vs. 43 (10)

p = 0.004
41 (9) vs. 43 (10)

43 (10) vs. 43 (10)

p = 0.002
40 (10) vs. 45 (10)

p = 0.024
41 (10) vs. 45 (10)

p = 0.001
41 (9) vs. 45 (10)

p = 0.389
43 (10) vs. 45 (10)

43 (10) vs. 45(10)

p < 0 .001

p < 0.001

p < 0.001

p = 0.001

p = 0.029

*Covariates include age and gender; PROMIS = Patient-reported Outcomes Measurement Information System; PF = Physical
Function.

when evaluated using a ½ SD, distribution-based method for
calculating MCID but not when using an anchor-based approach for calculating MCID. However, the difference between the highest and lowest income bracket for PROMIS
PI was clinically important when evaluated using either
calculation approach for MCID. Third, low-income patients
had a PASS that was associated with far worse symptoms
(up to approximately one SD worse in the PROMIS
domains) than did high-income patients, which reported
having a PASS when their symptoms were similar to the
average of the US population.
Our study has some limitations. First, we used an areabased income status measure. Although evaluating individual income levels may be preferred, previous research
has noted the lack of accurate data on income status in
clinical settings [12]. However, area-based income status
measures, including those determined using a similar
geocoding approach [7], have been used and were found to
be appropriate measurements in orthopaedic studies [16,
23]. Second, our ﬁndings may be speciﬁc to a tertiary care,
academic institution serving patients with orthopaedic foot
and ankle problems. Future work may consider factors
associated with income (for example, rural versus urban
settings) and other clinical populations at other care sites.
Third, we included all patients with foot and ankle problems presenting for new-patient visits, regardless of diagnosis. There could be differences in pathology, and it is
possible that that PROMIS and PASS may be more useful

for speciﬁc diagnoses. However, this work provides an
initial valuable overview that can support care discussions
and guide future work. Fourth, our patient sample had a
smaller number of nonwhite and non-Hispanic individuals
than does the county we serve (Table 1). This ﬁnding may
be due to a number of factors, including: (1) lack of health
care access and equity for such individuals; (2) selection of
foot and ankle providers from a competing health system;
(3) lack of foot and ankle pathology in nonwhite and nonHispanic individuals; and/or (4) a lack of interest in
seeing a foot and ankle specialist. Given this bias in our
sample, readers should be aware that our ﬁndings may not
reﬂect their own patient populations; thus, surgeons should
use caution in assuming that our PASS thresholds, for
example, are the same for foot and ankle patients in all
settings. Fifth, PROMIS and PASS may not work as well as
we suspect in terms of evaluating and differentiating perception of health, respectively. However, both instruments
have been previously evaluated; nonetheless, surgeons
should ensure that they continue to use their clinical experience and expertise in conjunction with the information
provided by these tools when providing care.
The only patient sociodemographic factor associated
with differences in the proportion of patients achieving
versus not achieving PASS was age. This ﬁnding differs
from previous studies done by Houck et al. [9] and Wright
et al. [22], which showed that there was no difference in
patient age between those achieving versus not achieving

Table 4. Two-way ANOVA with pairwise comparison to evaluate diﬀerences in mean PROMIS PI scores by income bracket*
Income bracket: Mean PROMIS PI score (SD) (horizontal column) vs. mean PROMIS PI score (SD) (vertical column)
£ USD 24,999 USD 25,000 to USD USD 35,000 to USD USD 50,000 to USD USD 75,000 to USD
(n = 89)
34,999 (n = 118)
49,999 (n = 429)
74,999 (n = 1083)
99,999 (n = 505)

Income bracket
# USD 24,999 (n = 89)
p value
USD 25,000-USD 34,999
(n = 118)
p value
USD 35,000-USD 49,999
(n = 429)
p value
USD 50,000-USD 74,999
(n = 1083)
p value
USD 75,000-USD 99,999
(n = 505)
p value
$ USD 100,000 (n = 373)
p value

63 (7) vs. 61 (8)
p = 0.051
63 (7) vs. 60 (8)

61 (8) vs. 60 (8)

p = 0.001
63 (7) vs. 59 (8)

p = 0.248
61 (8) vs. 59 (8)

60 (8) vs. 59 (8)

p < 0.001
63 (7) vs. 59 (8)

p = 0.040
61 (8) vs. 59 (8)

p = 0.166
60 (8) vs. 59 (8)

59 (8) vs. 59 (8)

p < 0.001
63 (7) vs. 57 (8)
p < 0.001

p = 0.025
61 (8) vs. 57 (8)
p < 0.001

p = 0.096
60 (8) vs. 57 (8)
p < 0.001

p = 0.572
59 (8) vs. 57 (8)
p < 0.001

59 (8) vs. 57 (8)
p < 0.001

*Covariates include age and gender; PROMIS = Patient-reported Outcomes Measurement Information System; PI = Pain
Interference.

PASS. However, the differences may be because we focused on only foot and ankle patients, while the previous
studies analyzed data from patients presenting to a primary

care provider or who were referred to an outpatient physical
therapist with any musculoskeletal concern [9, 22]. Other
potential reasons may be because the samples in the

Table 5. Two-way ANOVA with pairwise comparison to evaluate diﬀerences in mean PROMIS Depression scores by income bracket*
Income bracket: mean PROMIS Depression score (SD) (horizontal column) vs. mean PROMIS Depression score (SD) (vertical
column)
Income bracket
# USD 24,999 (n = 89)
p value
USD 25,000-USD
34,999 (n = 118)
p value
USD 35,000-USD
49,999 (n = 429)
p value
USD 50,000-USD
74,999 (n = 1083)
p value
USD 75,000-USD
99,999 (n = 505)
p value
$ USD 100,000
(n = 373)
p value

£ USD 24,999
(n = 89)

USD 25,000 to USD
34,999 (n = 118)

USD 35,000 to USD
49,999 (n = 429)

USD 50,000 to USD
74,999 (n = 1083)

USD 75,000 to USD
99,999 (n = 505)

51 (11) vs. 50 (10)
p = 0.251
51 (11) vs. 49 (9)

50 (10) vs. 49 (9)

p = 0.006
51 (11) vs. 47 (9)

p = 0.124
50 (10) vs. 47 (9)

49 (9) vs. 47 (9)

p < 0.001
51 (11) vs. 47 (9)

p = 0.001
50 (10) vs. 47 (9)

p = 0.008
49 (9) vs. 47 (9)

47 (9) vs. 47 (9)

p < 0.001
51 (11) vs. 46 (8)

p = 0.001
50 (10) vs. 46 (8)

p = 0.012
49 (9) vs. 46 (8)

p = 0.800
47 (9) vs. 46 (8)

47 (9) vs. 46 (8)

p < 0.001

p < 0.001

p < 0.001

p = 0.090

p = 0.197

*Covariates include age and gender; PROMIS = Patient-reported Outcomes Measurement Information System.

Table 6. Receiver operating characteristic curve analysis by income bracket for PROMIS thresholds to determine the PASS
Income bracket
All income brackets
PROMIS PF
PROMIS PI
PROMIS Depression
# USD 24,999
PROMIS PF
PROMIS PI
PROMIS Depression
USD 25,000-USD 34,999
PROMIS PF
PROMIS PI
PROMIS Depression
USD 35,000-USD 49,999
PROMIS PF
PROMIS PI
PROMIS Depression
USD 50,000-USD 74,999
PROMIS PF
PROMIS PI
PROMIS Depression
USD 75,000-USD 99,999
PROMIS PF
PROMIS PI
PROMIS Depression
$ USD 100,000
PROMIS PF
PROMIS PI
PROMIS Depression

Area under the curve (95% CI)

Threshold

Sensitivity

Speciﬁcity

0.72 (0.69-0.75)
0.74 (0.71-0.77)
0.60 (0.57-0.63)

45
56
46

68
68
58

67
70
57

0.69 (0.53-0.84)
0.59 (0.51-0.88)
0.67 (0.53-0.82)

39
59
46

85
69
62

54
76
70

0.67 (0.52-0.82)
0.72 (0.58-0.86)
0.54 (0.39-0.69)

48
58

56
63

75
70

0.70 (0.62-0.77)
0.70 (0.62-0.77)
0.56 (0.49-0.64)

45
57

58
60

72
68

0.73 (0.68-0.77)
0.76 (0.72-0.80)
0.62 (0.58-0.67)

47
56
46

63
73
64

74
72
55

0.73 (0.66-0.79)
0.73 (0.66-0.79)
0.60 (0.53-0.67)

47
57
46

69
69
57

73
63
55

0.76 (0.69-0.83)
0.79 (0.73-0.86)
0.59 (0.52-0.67)

49
53
47

75
69
63

71
77
55

PROMIS = Patient-reported Outcomes Measurement Information System; PASS = Patient-acceptable Symptom State; PF = Physical
Function; PI = Pain Interference.

previous studies are smaller than ours or because we dichotomized age (18-64 years versus $ 65 years) to provide
surgeons an easier starting point when engaging in shared
decision-making discussions when using our research,
while the previous studies kept age continuous [9, 22].
Further, Teunis et al. [19] found that age did not affect
patient satisfaction in a sample of patients seeking hand
care. Similar to Houck et al. [9], Teunis et al. [19] kept age
continuous, which may explain the difference in our ﬁndings. In addition, instead of using PASS, Teunis et al. [19]
used the Consumer Assessment of Healthcare Providers
and Systems survey, a federally developed tool. Thus, our
ﬁndings may differ because of the different instruments
used. Future work can evaluate whether PASS and the
Consumer Assessment of Healthcare Providers and Systems survey truly capture similar constructs, as measuring
patient satisfaction can be quite challenging [18].

Between the highest and the lowest income bracket
patients, PROMIS PF scores differed at a clinically important level when using a ½ SD, distribution-based approach but not when using an anchor-based approach; in
contrast, PROMIS PI scores differed at a clinically important level when using either MCID calculation method.
Indeed, high-income patients sought care when less impairment was present compared with low-income patients.
In a study of 403 patients with adolescent idiopathic scoliosis, Zavatsky et al. [25] did not ﬁnd difference in disease
severity as measured by Cobb angle based on income.
However, these ﬁndings may differ from ours for a few key
reasons: (1) the authors dichotomized income as below or
above USD 75,000, while we reported income in six
groups; (2) the authors collected income data directly from
patients, while we used a geocoding method; (3) the
authors considered the Cobb angle as a measure of disease

severity, while we measured clinical outcomes most important to patients using PROMIS. We feel that incorporating both objective disease-related measurements
(such as the Cobb angle) and PROMs are needed to deliver
the highest quality care, as both offer insight needed to
guide treatment discussions and decisions. However, in a
heterogeneous sample of foot and ankle patients, there is no
similar measurement to the Cobb angle for all patients;
thus, in such a population, PROMs may offer the best
method of evaluating patient health, and surgeons should
be aware that regardless of what imaging or other objective
measurements show, foot and ankle patients of lower income status may report clinically worse symptoms at presentation. This ﬁnding is similar to that found in a study of
367 patients presenting with carpal tunnel syndrome,
which showed that patients with higher levels of social
deprivation had worse PROMIS scores than those with
lower levels of social deprivation [23]. Overall, it is important to note that whether or not there is a true clinical
difference in mean PROMIS scores between patients in
different income brackets is based on the method of calculating the MCID. If surgeons ultimately agree upon a
method of calculating the MCID, our results can be
reevaluated in that light.
Perhaps the most interesting ﬁnding of our study is that
the PASS thresholds of the PROMIS PF and PI differed
based on income level. Between the highest and lowest
income brackets, the PASS thresholds of the PROMIS PF
and PI differed by one SD (10 points) and more than onehalf of an SD (6 points) worse than those of the US population, respectively. PROMIS PF and PI showed a modest
level of differentiation for different income levels, while
PROMIS Depression did not provide useful clinical discrimination. Interestingly, this appears to contradict a study
by Barrack et al. [2], which found that patients with lower
income are less satisﬁed after TKA than patients with
higher income. However, this may not be truly contradictory to our ﬁndings, as it is possible that the difference may
be in the fact that if patients of lower income end up receiving operative care, they then have high clinical outcome expectations to be satisﬁed. Future work would need
to determine if this is the case. Nonetheless, the ﬁnding that
PASS differs based on income raises an important question: Should PASS be used to evaluate patient satisfaction
with health status even though it is affected by patient income? While the simplicity of a single question is enticing,
it is possible that a more robust method of evaluating a
patient’s ability to cope with his or her health status is
warranted to ensure consistency across patient groups. This
would allow surgeons to know whether a patient is truly
satisﬁed or dissatisﬁed without having to consider patient
income, which may not be readily available. In its current
form, we believe PASS still offers insight into patient
satisfaction and ability to cope with a given symptom state

uncaptured by PROMIS; however, patients should then be
stratiﬁed by income to compare “apples to apples.” An
updated PASS question or series of questions, if needed,
that risk-adjusts for income would be beneﬁcial. Future
work should aim to accomplish this goal.
In conclusion, this study shows that: (1) the proportion
of patients achieving PASS in a foot and ankle patient
sample is higher in younger patients; (2) patients in a lower
income bracket present for foot and ankle care when their
symptoms are worse compared with patients in a higher
income bracket; and (3) a patient’s income inﬂuences his or
her judgement of whether symptoms and activity level are
satisfactory (PASS). Despite the impact of patient income
on PASS, this validated question provides information on
patient satisfaction and coping ability uncaptured by
PROMIS; thus, it can help guide expectation-setting and
shared decision-making discussions regarding treatment
options. However, future work should look to create a
PASS question, or set of questions, that risk-adjust for income so that it is no longer biased based on this patient
sociodemographic factor. Until then, stratifying patients by
income may be the best approach. Additional research can
also better determine why patients from lower income
brackets present for foot and ankle care when their symptoms are worse. Furthermore, future research can determine whether similar ﬁndings are present when
evaluating treatment outcomes using PROMIS and PASS
when accounting for income and other patient sociodemographic factors. Despite there being no clear deﬁnition of health care quality to date [4], this study builds upon
previous work by helping us to better understand the relationship between PROMIS, PASS, and patient sociodemographic factors so that we can care for patients with
varied backgrounds and income levels as best as possible.
Acknowledgments None.
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